Introduction |
|
x | |
|
Section 1 Long-COVID Disease |
|
|
1 | (54) |
|
1 Long-COVID Disease or Long-COVID Syndrome? |
|
|
3 | (21) |
|
|
3 | (1) |
|
Long-COVID Disease or Syndrome? |
|
|
4 | (4) |
|
Long COVID in Hospitalized Patients |
|
|
8 | (3) |
|
Long COVID in Non-hospitalized Patients |
|
|
11 | (3) |
|
Comparing Hospitalized and Non-hospitalized Patients |
|
|
14 | (1) |
|
|
15 | (3) |
|
|
16 | (2) |
|
|
18 | (2) |
|
|
20 | (4) |
|
2 Lung, Heart Disease, and Other Organ Damage |
|
|
24 | (15) |
|
|
24 | (3) |
|
Persistent Dyspnea, Not Always Correlated with Pulmonary Damage |
|
|
26 | (1) |
|
|
27 | (5) |
|
Is There Unanticipated Long-term Cardiac Damage? |
|
|
30 | (2) |
|
|
32 | (1) |
|
|
33 | (1) |
|
|
34 | (5) |
|
3 COVID-19 Direct Effects on the Central Nervous System |
|
|
39 | (16) |
|
|
39 | (2) |
|
There are Multiple Ways for Infections to Disturb the Nervous System |
|
|
40 | (1) |
|
|
41 | (11) |
|
Loss of Senses of Smell and Taste |
|
|
42 | (3) |
|
|
45 | (2) |
|
Hypoxic Brain Damage and the Post-ICU Syndrome |
|
|
47 | (3) |
|
Guillian-Barre Syndrome and Other Neuropathies - Effects of COVID-19 on Peripheral Nerves |
|
|
50 | (1) |
|
Other Neurological Disorders Due to Acute COVID-19 |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
52 | (3) |
|
Section 2 Long-COVID Syndrome and Unexplained Symptoms |
|
|
55 | (44) |
|
4 Unexplained Symptoms: Medicine's Blind Spot |
|
|
57 | (21) |
|
|
57 | (2) |
|
|
59 | (4) |
|
Chronic Fatigue in the General Population |
|
|
59 | (3) |
|
Chronic Fatigue in Long-COVID Syndrome |
|
|
62 | (1) |
|
|
63 | (3) |
|
Cognitive Disturbances in the General Population |
|
|
63 | (1) |
|
Cognitive Disturbances in Long-COVID Syndrome |
|
|
64 | (2) |
|
|
66 | (1) |
|
In the General Population |
|
|
66 | (1) |
|
Unexplained Dyspnea in Long COVID |
|
|
66 | (1) |
|
|
67 | (2) |
|
Chronic Pain in the General Population |
|
|
67 | (1) |
|
Chronic Pain in Long-COVID Syndrome |
|
|
68 | (1) |
|
|
69 | (1) |
|
Headaches in the General Population |
|
|
69 | (1) |
|
Headaches in Long-COVID Syndrome |
|
|
69 | (1) |
|
|
70 | (1) |
|
Sleep Disturbances in the General Population |
|
|
70 | (1) |
|
Sleep Disturbances in Long-COVID Syndrome |
|
|
71 | (1) |
|
|
71 | (1) |
|
In the General Population |
|
|
71 | (1) |
|
Mood Disturbances in Long COVID |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
73 | (5) |
|
5 Historical Perspectives, Including Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Fibromyalgia |
|
|
78 | (21) |
|
Chronic Fatigue Syndrome, Myalgic Encephalomyelitis (CFS/ME) |
|
|
78 | (2) |
|
|
80 | (2) |
|
CFS/ME, Fibromyalgia in Long-COVID |
|
|
82 | (1) |
|
Post-treatment Lyme-disease Syndrome (PTLDS) |
|
|
83 | (2) |
|
Similar Patient Characteristics |
|
|
85 | (1) |
|
Shared Illness Mechanisms |
|
|
86 | (2) |
|
Lessons Learned from CFS/ME, Fibromyalgia, PTLDS |
|
|
88 | (2) |
|
Syndrome, Disease, and Diagnostic Labels |
|
|
88 | (2) |
|
|
90 | (1) |
|
Patient-Physician Information and Misinformation |
|
|
91 | (2) |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
95 | (4) |
|
Section 3 Mechanisms and Pathways |
|
|
99 | (38) |
|
6 Brain Homeostasis Run Amok |
|
|
101 | (19) |
|
Brain Homeostasis in Health and Disease |
|
|
101 | (1) |
|
Our Physical Brain Regulates Our Thoughts |
|
|
102 | (1) |
|
Brain Circuits and Networks |
|
|
103 | (2) |
|
|
105 | (2) |
|
|
107 | (2) |
|
Detecting Structural and Functional Brain Changes |
|
|
109 | (4) |
|
Changes in the Autonomic Nervous System, Neurohormones, and the Stress Response |
|
|
113 | (4) |
|
|
117 | (1) |
|
|
117 | (3) |
|
7 Neuroimmune Dysfunction |
|
|
120 | (17) |
|
Is Long COVID an Autoimmune Disease? |
|
|
120 | (3) |
|
Evidence that Long-COVID Syndrome is a Neuroimmune Disorder |
|
|
123 | (2) |
|
|
125 | (2) |
|
Autoantibodies in Long-COVID Syndrome |
|
|
127 | (2) |
|
Can Vaccines also Cause Autoimmune Reactions? |
|
|
129 | (1) |
|
Immune Tests for Long COVID |
|
|
129 | (2) |
|
Neuroimmune Studies in CFS/ME, Fibromyalgia, and Depression |
|
|
131 | (1) |
|
Is a Unifying Theory of How Long-COVID Syndrome Develops Possible? |
|
|
131 | (2) |
|
|
133 | (1) |
|
|
134 | (3) |
|
Section 4 Evaluation and Management |
|
|
137 | (95) |
|
8 Patient Evaluation and Research |
|
|
139 | (18) |
|
Need: Widely Accepted Long-COVID Term and Case Definition |
|
|
139 | (1) |
|
Need: Uniform Symptom and Outcome Measures |
|
|
140 | (2) |
|
Initial Evaluation, Primary Care Role |
|
|
142 | (3) |
|
|
145 | (4) |
|
|
149 | (2) |
|
General Clinical Research |
|
|
151 | (1) |
|
|
152 | (1) |
|
|
153 | (1) |
|
|
153 | (4) |
|
9 Patient Management and Rethinking Healthcare Amid Long COVID |
|
|
157 | (21) |
|
|
157 | (1) |
|
|
157 | (1) |
|
Pulmonary and Physical Rehabilitation |
|
|
158 | (1) |
|
|
159 | (2) |
|
Evaluate and Treat Autonomic Dysfunctions and Postural Orthostatic Tachycardia Syndrome |
|
|
161 | (1) |
|
Psychological Rehabilitation |
|
|
162 | (1) |
|
Medications and Other Therapies |
|
|
163 | (1) |
|
|
164 | (1) |
|
Health Coverage, Disability |
|
|
165 | (1) |
|
Rethinking Healthcare Amid Long COVID |
|
|
166 | (1) |
|
Dealing with Medical Uncertainty |
|
|
166 | (1) |
|
|
167 | (3) |
|
Integrated, Patient-centric Care |
|
|
170 | (1) |
|
A Biopsychosocial Illness Model |
|
|
171 | (3) |
|
|
174 | (4) |
|
10 The Way Forward: For Patients, Healthcare Providers, and Research |
|
|
178 | (54) |
|
|
178 | (2) |
|
|
178 | (2) |
|
Where Do I Go for a Diagnosis? |
|
|
180 | (1) |
|
Assessing Illness Severity |
|
|
180 | (1) |
|
General Principles You Should Know |
|
|
181 | (1) |
|
|
182 | (1) |
|
Avoiding Misinformation and Disinformation |
|
|
183 | (2) |
|
Disability and Disability Insurance |
|
|
185 | (1) |
|
Biopsychological Perspectives to Remember |
|
|
186 | (1) |
|
|
187 | (4) |
|
|
187 | (4) |
|
|
191 | (2) |
|
Research, Patients, and the Public |
|
|
193 | (8) |
|
|
193 | (2) |
|
Bringing Long-COVID Patients and Researchers Together |
|
|
195 | (3) |
|
|
198 | (3) |
|
A New Chronic Illness Strategy |
|
|
201 | (3) |
|
|
204 | (1) |
|
|
205 | (3) |
|
Appendix A Long-COVID Clinics in the US and Europe |
|
|
208 | (9) |
|
Appendix B Suggestions for Future Research Focused on the Cellular and Molecular Basis of Long-COVID Syndrome |
|
|
217 | (15) |
|
Hypothesis 1 Brain-restricted Autoimmunity causes Long-COVID Syndrome |
|
|
217 | (1) |
|
|
217 | (1) |
|
|
218 | (1) |
|
How Else Might SARS-CoV-2 Infection Influence the Immune Response Leading to Long COVID? |
|
|
219 | (3) |
|
Hypotheses 2 SARS-CoV-2 Infection Alters the Microbiome, which in turn Initiates Long-COVID Syndrome |
|
|
222 | (1) |
|
What is the Microbiome and How does it Affect Immunity and the Brain? |
|
|
222 | (2) |
|
The Microbiome in COVID-19 Patients and in Individuals with Long-COVID Syndrome |
|
|
224 | (2) |
|
Hypothesis 3 Long-COVID Syndrome is Related to Persistent SARS-CoV-2 Virus or Virus Fragments Sequestered in Brain Cells |
|
|
226 | (1) |
|
|
226 | (3) |
|
|
229 | (3) |
Index |
|
232 | |